Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
Gregg W. Stone(Cardiovascular Institute of the South), Valentı́n Fuster(Mount Sinai Hospital), Deepak L. Bhatt(Mount Sinai Hospital), Ovidiu Dressler(Cardiovascular Research Foundation), Lucas C. Godoy(University of Toronto), Carlos Granada(Digital Science (United States)), Rodrigo Barbosa Ésper, Stuart Pocock(London School of Hygiene & Tropical Medicine), Alejandro Ricalde, Anuradha Lala(NewYork–Presbyterian Hospital), Jessica Bustamante(Cardiovascular Institute of the South), Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Alexandre Abizaid(Universidade de São Paulo), Gerardo Payró(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Pedro Moreno(Mount Sinai Hospital), Igor F. Palacios(Massachusetts General Hospital), Michael E. Farkouh(Cedars-Sinai Smidt Heart Institute), Shaun G. Goodman(University of Toronto), Girish N. Nadkarni(Icahn School of Medicine at Mount Sinai), Gennaro Giustino(Cardiovascular Institute of the South), Juan Felipe Betancur, Solomon Bienstock(Cardiovascular Institute of the South), Anton Camaj(Cardiovascular Institute of the South), Jason Feinman(Cardiovascular Institute of the South), Deepak Varade, Carlos Peyra(Cardiovascular Institute of the South), José María Castellano(HM Hospitales), Johanna Contreras, Elizabeth Tinuoye(Cardiovascular Institute of the South), Remo H.M. Furtado, Ruth Owen(Spanish National Centre for Cardiovascular Research)
Cited by 60
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k